Keywords: sandoz, gene, therapy, brain, cancer, efficacy, trial

Sandoz' Gene Therapy In Brain Cancer

Article | 07 October 1996

Print This

- An efficacy trial of gene therapy in brain cancer patients has been initiated by Sandoz Pharmaceuticals. The therapy, GLI-328, is ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in